Elbit Imaging Ltd. (EMITF-M.TA)

ILA 529.7

(1.87%)

Market Cap (In ILA)

56.1 Million

Revenue (In ILA)

328 Thousand

Net Income (In ILA)

-18.14 Million

Avg. Volume

2236.00

Currency
ILA
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.3-533.4
PE
-
EPS
-
Beta Value
0.589
ISIN
IL0010811169
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Ron Hadassi BA, LL.B, MBA
Employee Count
-
Website
-
Ipo Date
2000-01-03
Details
Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007. Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Petach Tikva, Israel.